Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-06

Clinical Trial Update: Phase II Clinical Trial of De-Intensified Therapy in Human Papilloma Virus (HPV) Associated Oropharyngeal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating de-intensified therapy for HPV-associated oropharyngeal squamous cell carcinoma is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Vermont Medical Center | Conditions: OPSCC, Oropharyngeal Squamous Cell Carcinoma (SCC) | Phase 2 | Status: NOT_YET_RECRUITING